Close Menu
Global News HQ
    What's Hot

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    June 28, 2025

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    June 28, 2025

    The 5 Best Stocks to Buy With $5,000 | The Motley Fool

    June 28, 2025
    Recent Posts
    • Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality
    • Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality
    • The 5 Best Stocks to Buy With $5,000 | The Motley Fool
    • Kenzo Spring 2026 Menswear Collection
    • XRP spikes 3% after Garlinghouse says Ripple dropping SEC cross-appeal
    Facebook X (Twitter) Instagram YouTube TikTok
    Trending
    • Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality
    • Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality
    • The 5 Best Stocks to Buy With $5,000 | The Motley Fool
    • Kenzo Spring 2026 Menswear Collection
    • XRP spikes 3% after Garlinghouse says Ripple dropping SEC cross-appeal
    • 10 Outdated Travel Items It’s Time to Toss—and What to Replace Them With, From $13
    • PwC to cut 175 junior auditors amid slowdown
    • Are You Approachable at Work? Tips for Building Better Connections
    Global News HQ
    • Technology & Gadgets
    • Travel & Tourism (Luxury)
    • Health & Wellness (Specialized)
    • Home Improvement & Remodeling
    • Luxury Goods & Services
    • Home
    • Finance & Investment
    • Insurance
    • Legal
    • Real Estate
    • More
      • Cryptocurrency & Blockchain
      • E-commerce & Retail
      • Business & Entrepreneurship
      • Automotive (Car Deals & Maintenance)
    Global News HQ
    Home - Health & Wellness (Specialized) - How to Shorten a Flare-Up of Crohn’s Disease
    Health & Wellness (Specialized)

    How to Shorten a Flare-Up of Crohn’s Disease

    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    How to Shorten a Flare-Up of Crohn’s Disease
    Share
    Facebook Twitter LinkedIn Pinterest Email


    A Crohn’s flare occurs when a dysfunctional immune response causes inflammation in your digestive system and elsewhere in your body.

    Treatment can consist of short-term therapies for use during flares as well as long-term maintenance therapy. Treatment during a flare aims to relieve symptoms and bring about remission, or the end of the flare.

    Anti-Inflammatory Drugs for Short-Term Use

    During a flare, short-term use of anti-inflammatory drugs, such as steroids, can help improve symptoms by reducing inflammation. Your doctor may prescribe them alongside other drugs.

    • Corticosteroids Prednisone (Deltasone) and budesonide (Entocort EC) can relieve symptoms and bring about remission. But long-term steroid use can have severe adverse effects, so doctors generally recommend using them for short periods as a bridge to other therapies.

    Pain-Relieving Medication

    Pain-relieving medications won’t shorten a Crohn’s flare, but they can decrease discomfort while you wait for other drugs to work. These include:

    • Antispasmodics, such as dicyclomine (Bentyl), which reduce cramps
    • Acetaminophen, such as Tylenol, which relieves pain
    Doctors may sometimes prescribe opioids for severe abdominal pain with IBD, but they can have many adverse effects, including digestive upset and a risk of dependence.

    Opioids may also worsen IBD outcomes, so be sure to discuss their pros and cons with your doctor before using them.

    Biologics and Other Long-Term Treatments

    Long-term drugs, also called maintenance therapy, change how the immune system works. Biologics, which stop certain proteins in the body from causing inflammation, are antibody-based drugs made from substances that occur naturally.

     Nonbiologics, which target the body’s immune response, are drugs created from synthetic substances, such as anti-inflammatories and immunosuppressive medications.

    Both classes of drugs can reduce the risk of Crohn’s flares and the severity of symptoms, bring about remission during a flare, and help maintain remission for extended periods.

    It’s important for your doctor to monitor your use of these drugs, as suppressing the immune system can have adverse effects, such as a higher risk of infections.

     The following are some options.

    • Anti-TNF agents such as infliximab (Remicade) and adalimumab (Humira) can shorten a flare. These biologic drugs dampen the immune response by targeting specific molecules and blocking the action of a protein known as tumor necrosis factor, which causes inflammation.

    • IL-12/23 and IL-23 inhibitors such as ustekinumab (Stelara) and risankizumab (Skyrizi), respectively, are also biologic drugs. They reduce inflammation by blocking proteins known as interleukins, which play a role in activating the body’s immune response.

    • Integrin blockers reduce Crohn’s-related inflammation by targeting precise molecules linked to the gut. Vedolizumab (Entyvio), a biologic drug, blocks the production of one type of integrin, a protein that enables inflammation-causing cells to move from the blood into tissues. It can also act as a maintenance drug between flares.

    • JAK inhibitors, which are nonbiologic synthetic small molecule drugs, may relieve symptoms more quickly than other nonsteroid drugs. They reduce inflammation by blocking substances that lead to a faulty immune response, and they can also prevent recurrent flares.

      In clinical trials, 58.8 percent felt symptom relief after two weeks.

       Upadacitinib (Rinvoq) was the first JAK inhibitor to get approval from the U.S. Food and Drug Administration (FDA) for treating Crohn’s.

    • Immunomodulators such as methotrexate (Trexall) and azathioprine (Imuran) are nonbiologic drugs that reduce inflammation by changing how the immune system works. But it can take 8 to 12 weeks to see an improvement after you start immunomodulators, so they’re not typically used alone for treating acute flares.

    Will My Meds Change During a Flare?

    A Crohn’s flare doesn’t necessarily mean your medication regimen has stopped working or that you’ll have to change it, says Sobia Mujtaba, MD, MPH, a gastroenterologist and an assistant professor at the Emory University School of Medicine in Atlanta.

    “While that is one reason for a flare, [that] a certain medication has lost efficacy, other reasons include infections, or if a medication needs to be optimized,” she says.

    Drugs to Avoid

    Nonsteroidal anti-inflammatory drugs (NSAIDs) may worsen symptoms in people with Crohn’s, so check with your doctor before using them.

    Speak with your doctor before starting or changing any drug or treatment, including over-the-counter drugs, to make sure they won’t worsen your symptoms or interact with other medications.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleHilton Honors devalues stays at high-end properties – The Points Guy
    Next Article DOJ to press on with criminal charges against Tornado Cash developer Roman Storm

    Related Posts

    Lung Cancer Doctors, Nurses, Therapists, and More: Your Metastatic Non-Small Cell Lung Cancer Team

    June 28, 2025

    This Month's Cancer New Moon Brings Big Emotions—Here's What To Know

    June 28, 2025

    A Shopper Swears This $20 Cream ‘Restored’ Firmness to Their Wrinkly ‘Turkey Neck’

    June 28, 2025

    3 Firming Skin Care Tips For Those 60+ (Research-Backed!)

    June 27, 2025
    Leave A Reply Cancel Reply

    ads
    Don't Miss
    Technology & Gadgets
    4 Mins Read

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    Asus has announced its newest GeForce RTX 5090 and GeForce RTX 5070 Ti under the…

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    June 28, 2025

    The 5 Best Stocks to Buy With $5,000 | The Motley Fool

    June 28, 2025

    Kenzo Spring 2026 Menswear Collection

    June 28, 2025
    Top
    Technology & Gadgets
    4 Mins Read

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    Asus has announced its newest GeForce RTX 5090 and GeForce RTX 5070 Ti under the…

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    June 28, 2025

    The 5 Best Stocks to Buy With $5,000 | The Motley Fool

    June 28, 2025
    Our Picks
    Technology & Gadgets
    4 Mins Read

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    Asus has announced its newest GeForce RTX 5090 and GeForce RTX 5070 Ti under the…

    Technology & Gadgets
    4 Mins Read

    Asus’s new BTF GPUs can now be used in standard systems courtesy of a detachable 1000W power connector — New 5090 and RTX 5070 Ti models have a dual personality

    Asus has announced its newest GeForce RTX 5090 and GeForce RTX 5070 Ti under the…

    Pages
    • About Us
    • Contact Us
    • Disclaimer
    • Homepage
    • Privacy Policy
    Facebook X (Twitter) Instagram YouTube TikTok
    • Home
    © 2025 Global News HQ .

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version